Literature DB >> 3236018

Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory.

B E Levin1, M M Llabre, W J Weiner.   

Abstract

Although the Beck Depression Inventory (BDI) is one of the most frequently employed measures of depression in Parkinson's disease, the somatic items included in the scale raise questions about its ability to differentiate depression from manifestations of the disease. The internal consistency and validity of the BDI as a measure of depression in a sample of 119 Parkinson's disease patients and 76 controls were studied. Results from an item analysis suggested that depression in Parkinson's disease patients is not a somatic artifact. Internal consistency reliability within the Parkinson's disease group was high. The factorial validity of the BDI was confirmed in both Parkinson's disease and control subjects. The results also indicated that Parkinsonian symptoms of depression can be measured separately from symptoms of the disease. These data suggest that the BDI including the somatic items is a reliable and valid measure of depression in Parkinson's disease and control subjects.

Entities:  

Mesh:

Year:  1988        PMID: 3236018      PMCID: PMC1032810          DOI: 10.1136/jnnp.51.11.1401

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Comparative studies of psychological function in patients with advanced cancer--I. Self-reported depressive symptoms.

Authors:  M M Plumb; J Holland
Journal:  Psychosom Med       Date:  1977 Jul-Aug       Impact factor: 4.312

2.  Depressive symptoms in Parkinson patients referred for thalamotomy.

Authors:  J W Warburton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-08       Impact factor: 10.154

3.  The communication of affection between cancer patients and their spouses.

Authors:  L Leiber; M M Plumb; M L Gerstenzang; J Holland
Journal:  Psychosom Med       Date:  1976 Nov-Dec       Impact factor: 4.312

4.  Depression, intellectual impairment, and Parkinson disease.

Authors:  R Mayeux; Y Stern; J Rosen; J Leventhal
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

Review 5.  Movement disorders in the psychiatric patient.

Authors:  D A Moros; M D Yahr
Journal:  Hosp Community Psychiatry       Date:  1984-04

6.  Parkinson's disease and depression. A critical re-evaluation.

Authors:  A E Taylor; J A Saint-Cyr; A E Lang; F T Kenny
Journal:  Brain       Date:  1986-04       Impact factor: 13.501

7.  Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.

Authors:  L K Direnfeld; M L Albert; L Volicer; P J Langlais; J Marquis; E Kaplan
Journal:  Arch Neurol       Date:  1984-09

8.  Some psychological factors in Parkinsonism.

Authors:  S Horn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-01       Impact factor: 10.154

9.  Psychic and somatic symptoms of depression among young adults, institutionalized aged and noninstitutionalized aged.

Authors:  R Zemore; N Eames
Journal:  J Gerontol       Date:  1979-09

10.  Depression in patients with Parkinsonism.

Authors:  A H Robins
Journal:  Br J Psychiatry       Date:  1976-02       Impact factor: 9.319

View more
  37 in total

1.  Apathy and depression: separate factors in Parkinson's disease.

Authors:  Lindsey Kirsch-Darrow; Michael Marsiske; Michael S Okun; Russell Bauer; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2011-11       Impact factor: 2.892

2.  Pseudobulbar affect: prevalence and quality of life impact in movement disorders.

Authors:  Roy E Strowd; Michael S Cartwright; Michael S Okun; Ihtsham Haq; Mustafa S Siddiqui
Journal:  J Neurol       Date:  2010-04-08       Impact factor: 4.849

3.  Depression and intelligence in patients with Parkinson's disease and deep-brain stimulation.

Authors:  Courtney R Schadt; Katie L Cox; Michael G Tramontana; Daniel W Byrne; Thomas L Davis; John Y Fang; Peter E Konrad; Bhavna Padaliya; Robert W Mutter; Chandler E Gill; Caralee R Richardson; P David Charles
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

4.  Specificity of affective and autonomic symptoms of depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; A W Forrester; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

5.  Depression rating scales in Parkinson's disease: critique and recommendations.

Authors:  Anette Schrag; Paolo Barone; Richard G Brown; Albert F G Leentjens; William M McDonald; Sergio Starkstein; Daniel Weintraub; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

6.  Subthreshold depression in Parkinson's disease.

Authors:  Daniel A Nation; Heather L Katzen; Spyridon Papapetropoulos; Blake K Scanlon; Bonnie E Levin
Journal:  Int J Geriatr Psychiatry       Date:  2009-09       Impact factor: 3.485

7.  Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Authors:  Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Katia Longo; Autilia Cozzolino; Dario Grossi; Paolo Barone
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

Review 8.  Depression in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

9.  Adaptation and psychometric properties of the Italian version of the Non-Motor Symptoms Questionnaire for Parkinson's disease.

Authors:  I Cova; M E Di Battista; N Vanacore; C P Papi; G Alampi; A Rubino; M Valente; G Meco; P Contri; A Di Pucchio; E Lacorte; A Priori; C Mariani; S Pomati
Journal:  Neurol Sci       Date:  2017-02-01       Impact factor: 3.307

10.  Effects of sleep disorders on the non-motor symptoms of Parkinson disease.

Authors:  Ariel B Neikrug; Jeanne E Maglione; Lianqi Liu; Loki Natarajan; Julie A Avanzino; Jody Corey-Bloom; Barton W Palmer; Jose S Loredo; Sonia Ancoli-Israel
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.